Ocrelizumab-Induced Leukocyte Subpopulations Dynamics in Multiple Sclerosis. De Masi R, Orlando S Pharmaceuticals (Basel). 2026 Sep 23; 19(10). PMID: 42943211. Abstract CommentRecommendBookmarkWatch